A detailed history of Maven Securities LTD transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Maven Securities LTD holds 850,000 shares of WVE stock, worth $11.2 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
850,000
Holding current value
$11.2 Million
% of portfolio
0.9%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $4.35 Million - $7.66 Million
850,000 New
850,000 $6.97 Million
Q4 2023

Feb 12, 2024

BUY
$4.16 - $6.87 $6.04 Million - $9.98 Million
1,452,778 New
1,452,778 $7.34 Million
Q3 2021

Nov 15, 2021

SELL
$4.89 - $7.12 $1.52 Million - $2.22 Million
-311,768 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$5.65 - $7.47 $296,161 - $391,562
-52,418 Reduced 14.39%
311,768 $2.08 Million
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $1.87 Million - $4.01 Million
334,186 Added 1113.95%
364,186 $2.04 Million
Q4 2020

Feb 12, 2021

BUY
$6.99 - $9.26 $209,700 - $277,800
30,000 New
30,000 $236,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.14B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.